Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| KRONIKGUNE Cronicity Research Centre | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | No Intervention | routine care for the selection, placement and maintenance of venous access devices (VAD). | |
| Infusion Therapy Nursing Expert | Experimental | Patients in this group will receive the infusion therapy nursing expert (ITNE) service. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Infusion therapy nursing expert service | Other | The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD. If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home. If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device. |
| Measure | Description | Time Frame |
|---|---|---|
| Hospital Length of Stay | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Venous Access Devices reaching end of treatment | 3 months | |
| Incidence of complications derived from VAD | 3 months | |
| Patients receiving intravenous therapy at home |
Not provided
Inclusion Criteria:
Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy.
Be patient at Araba University Hospital
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lucia Garate, MsC | Basque Health Service | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Araba University Hospital | Vitoria-Gasteiz | Araba | 01009 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 3 months |
| Patient satisfaction with VAD | 3 months |